Analysis of Pre-participation Screening Protocols for Football Players in Europe, USA, and Libya: Possible Implications for Preventing Sudden Cardiac Death

Ani kardiyak ölüm, sporcular için önde gelen ölüm nedenidir ve tanısı konmamış kalp has-- talıklarından kaynaklanabilir. Spora katılım öncesi değerlendirmelerle ani kalp krizi riski taşıyan sporcuların belirlenebileceği konusunda evrensel görüş birliği bulunmakla birlikte, halihazırda yaygın kabul gören bir protokol yoktur. Avrupa Kardiyoloji Derneği (ESC) ve Amerikan Kalp Der-- neği (AHA), sporcuların ani ölümlerini önlemek için rutin taramalar önermelerine rağmen, proto-- kollerin yönergeleri konusunda önemli bir anlaşmazlık vardır. Avrupa Kardiyoloji Derneği'nin protokolü detaylı tıbbi geçmiş ve fizik muayene ile 12 derivasyonlu elektrokardiyografi içermesi-- ne karşın, Amerikan Kalp Derneği protokolü ayrıntılı tıbbi öykü ve fizik muayene içermektedir. Elektrokardiyografi kullanmanın maliyet--yarar oranının gözetilmesi, eğer taramalar nadir bulu-- nan hastalıklarla ilişkili ani ölümü önlemek için kullanılıyorsa tartışmalıdır. Libya Futbol Federas-- yonu 2013--2014 sezonunda Libya'lı futbolcular için, tıbbi geçmiş, fizik muayene, 12 derivasyonlu elektrokardiyografi, ekokardiyografi ve kan testlerini içeren yeni bir spora katılım öncesi sağlık değerlendirmesi protokolü oluşturdu. Maliyet ve protokol farklılıkları ne olursa olsun, sporcular-- da ani kardiyak ölümün görülme sıklığını azaltmak için spora katılım öncesi sağlık taramaları ol-- dukça önemlidir. Bu derleme, farklı protokolleri ve bunların ani kardiyak ölüm riski altındaki sporcuları belirlemedeki etkinliklerini incelemektedir.

Avrupa, Amerika Birleşik Devletleri ve Libya'daki Futbol Oyuncuları için Uygulanan Spora Katılım Öncesi Tarama Protokollerinin Analizi: Ani Kardiyak Ölümü Önlemede Olası Etkinlikleri

Sudden cardiac death is the leading cause of death in sport participants and may result from undiagnosed cardiac diseases. It has been universally agreed upon that pre—participation screening can identify those athletes at risk of sudden cardiac death, and yet, there is no commonly accepted protocol to screen athletes. Although the European Society of Cardiology (ESC) and the American Heart Association (AHA) recommend the routine screening of athletes to prevent sudden death, there is significant disagreement regarding the guidelines of the protocols. The American Heart Association protocol includes detailed medical history and physical examination, whereas the European Society of Cardiology protocol includes 12-lead electrocardiography with detailed medical history and physical examination. The cost benefit of using electrocardiography is debatable, particularly if the screening is used to prevent sudden death associated with uncommon diseases. The Libyan Football Federation established new seasonal pre—competition medical assessment protocol for Libyan football athletes during the 2013—2014 season, which includes medical history, physical examination, 12 lead electrocardiography, echocardiography, and blood test. Regardless of cost and differences in protocol, there is significant value in pre—participation screening for athletes in order to decrease the incidence of sudden cardiac death, and this report examines some of these different protocols as well as their potential for identifying athletes at risk for sudden cardiac death.

Kaynakça

. Shmied C, Borjesson M. Sudden cardiac death in athletes. Intern Med. 2014;27S(2]:93-103. doi: 10.1111/joim.12184.

2. Crawford MH. Screening athletes for heart disease. Heart 2007;93(’n:875-9. doi:10.1136/hrt. 2005.085365.

3. Alattar A, Ghani S, Mahdy N, et al. Pre-participation musculoskeletal and cardiac screening of male athletes in the United Arab Emirates. Trans! Med UniSa. 2014;9:43-9. eCollection 2014 Apr.

4. Maron B]. How should we screen competitive athletes for cardiovascular disease? Eur Heart]. 2005; 26:428-30.

5. Maron B]. Sudden death in young athletes. Engl Med. 2003;349:1064-75.

6. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. Am Coll Cardiol. 2008; 52(24]:1981-9.doi:10.1016/j.jacc.2008.06.053.

7. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?]Am Coll Cardiol. 2003;42:19S9-63.

8. Maron B], Shirani ], Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.]AMA. 1996;276:199-204.

9. Corrado D, Pelliccia A, Bjamstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardialand Pericardial Diseases of the European Society of Cardiology. Eur Heart]. 2005;26(5):516-24.

Corrado D, McKenna W]. Appropriate interpretation of the athlete's electrocardiogram saves lives as well as money. Eur Heart]. 2007;28(16]:1920-2.

Seto CK, Pendleton ME. Preparticipation cardiovascular screening in young athletes: current guidelines and dilemmas. Curr Sports Med Rep. 2009;8(2]:S9-64. doi:10.1249/]SR.0b013e31819ccdaf.

Magalski A, McCoy M, Zabel M, et al. Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes.Am]Med. 2011;124(6]: 511-8.

Sofi F, Capalbo A, Pucci N, et al. Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study. BM]. 2008;337:a346.

Bille K, Figueiras D, Schamasch P, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur] Cardiovasc Prev Rehabil. 2006;13(6]:859-7S.

Roberts WO, Löllgen H, Matheson GO, et al. Advancing the preparticipation physical evaluation: an ACSM and FIMS joint consensus statement. Clin Sport Med. 2014;24(6]:442-7. doi: 10.1097/]SM. 0000000000000168.

Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of preparticipation screening program.]AMA. 2006;296:1593-601.

Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. NEngl] Med. 1998;339:364-9.

Decree of the Italian Ministry of Health, February 18, 1982. Normeper la tutela sanitaria dell’attivita‘ sportiva agonistica (rules concerning the medical protection of athletic activity]. Gazzetta Ufficiale. March S, 1982:63.

Pelliccia A, Maron B]. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am Cardiol. 1995;75:827-9.

Löllgen H, Leyk D, Hansel ]. The preparticipation examination for leisure time physical activity. Dtsch Arztebl Int. 2010;107:742-9.

Maron B], Thompson PD, Puffer ]C, et al. Cardiovascular preparticipation screening of competitive athletes. statement for health professionals from the Sudden Death Committee (clinical cardiology] and Congenital Cardiac Defects Committee (cardiovascular disease in the young], American Heart Association. Circulation. 1996;94:850-6.

Riding NR, Sharma S, Salah O, et al. Systematic echocardiography is not efficacious when screening an ethnically diverse cohort of athletes in West Asia. Eur Prev Cardiol. 201S;22(2]:263-70. doi: 10.1177/2047487313506549. Epub 2013 Sep 20.

Grazioli G, Sanz M, Montserrat S, et al. Echocardiography in the evaluation of athletes. F1000Res. 2015;4:151.

Maron B], Thompson PD, Ackerman M], et al. American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12]:1643-SS. Epub 2007 Mar 12.

Dvorak ], Grimm K, Schmied C, et al. Development and implementation of standardized precompetition medical assessment of international elite football Pre-participation screening protocols players-2006 FIFA World Cup Germany. Clianport Med. 2009;19(4):316-21.

Dvorak ], Grimm K, Schmied C, et al. Feasibility of precompetition medical assessment at FIFA World Cups for female youth players. Br] Sports Med. 2012; 46(16]:1132-3. doi: 10.1136/bjsports-2011-090374. Epub 2011 Oct 20.

Sharif S. Echocardiography has low clinical efficacy of Libyan screening protocol in athletes. 16th National Sports Medicine Congress, 2017 April 2-5; Antalya, Turkey.

Sharma S, Merghani A, Gati S. Cardiac screening of young athletes prior to participation in sports, difficulties in detecting the fatally flawed among the fabulously fit. ]AMA Intern Med. 2015;175(1]:125-7. doi: 10.1001/jamainternmed. 2014.6023.

Kaynak Göster